Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares China Large-Cap ETF (FXI) vs Procter & Gamble Co (PG) Price & Performance

iShares China Large-Cap ETFTrade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

iShares China Large-Cap ETF vs Procter & Gamble Co — how do they compare? iShares China Large-Cap ETF trades at $33.87 (market cap $3.90B), while Procter & Gamble Co trades at $150 (market cap $343.34B). The key difference: Procter & Gamble Co is far larger — about 88× iShares China Large-Cap ETF's market cap, and Procter & Gamble Co pays a 2.95% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 149 Days and Procter & Gamble Co for 131 Days on average.

FXIPG
Market Cap
$3.90B$343.34B
Volume
16,526,4798,662,344
52-Week High
$41.08$167.18
52-Week Low
$31.59$138.10
Typical Hold Time
149 Days131 Days
Sector
—Consumer Staples
Enterprise Value
—$369.18B
Dividend Yield
—2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares China Large-Cap ETF

FXI (iShares China Large-Cap ETF) trades at $33.42, down 1.04% with a bearish technical outlook. The ETF shows compelling valuation at half the S&P 500's P/E ratio with a 1.98% yield, but faces headwinds from China's economic challenges and geopolitical tensions. Recent corporate profit growth of 26% in Q2 2026 provides fundamental support, though weak momentum persists amid global trade concerns.

The ETF offers diversification value and valuation appeal but carries significant political and economic risks. China's industrial overcapacity and weak domestic consumption create volatility, while U.S.-China relations remain a key variable. Institutional interest focuses on long-term value despite near-term bearish technical signals.

Procter & Gamble Co

Procter & Gamble (PG) trades at $150.59, up 1.47% today, with a bullish technical signal from moving averages and a consensus analyst price target of $160.13. The company reported revenue of $84.28 billion in 2025, with net income of $15.97 billion and strong profitability margins. Recent earnings have consistently beaten expectations, and the stock offers a dividend yield with a history of increases.

PG presents a stable investment with consistent earnings and dividend growth, supported by a robust balance sheet. Risks include premium valuation multiples and modest revenue growth outlook. Analyst sentiment is predominantly positive, with 53% buy ratings, but investors should monitor competitive pressures and economic sensitivity.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FXI
50% Buy50% Sell
Avg holding period · 149 Days
PG
91% Buy9% Sell
Avg holding period · 131 Days

Top news

Latest headlines on both assets

About iShares China Large-Cap ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.

Read more on FXI →

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG →